u/Economy-Break3583

First indirect comparison of two FDA-approved bladder-sparing strategies for BCG-unresponsive NMIBC: NAI + BCG vs TAR-200.
After MAIC adjustment:
🎯 12-mo CR:
• NAI+BCG: 49.2%
• TAR-200: 45.9%
⚠️ TRAEs:
• 61.7% with NAI+BCG
• 83.5% with TAR-200
→ ~68% lower odds of treatment-related toxicity with NAI+BCG (OR 0.32)